Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 76.19 percent increase over losses of $(0.21) per share from the same period last year.
Needham Maintains Buy on Sprout Social, Raises Price Target to $160
Needham analyst Scott Berg maintains Sprout Social (NASDAQ:SPT) with a Buy and raises the price target from $110 to $160.